Cargando…

Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018

In 2010 in Latvia, invasive pneumococcal disease (IPD) became a cause for concern and vaccination of infants with four doses of 7–valent pneumococcal conjugate vaccine (PCV7) commenced. In 2012, 10–valent pneumococcal conjugate vaccine (PCV10) (three doses at 2, 4, and 12–15 month of age) vaccinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Savrasova, Larisa, Krumina, Angelika, Cupeca, Hedija, Zeltina, Indra, Villerusha, Anita, Grope, Ilze, Viksna, Ludmila, Dimina, Elina, Balasegaram, Sooria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529945/
https://www.ncbi.nlm.nih.gov/pubmed/34692599
http://dx.doi.org/10.3389/fped.2021.532489
_version_ 1784586570566729728
author Savrasova, Larisa
Krumina, Angelika
Cupeca, Hedija
Zeltina, Indra
Villerusha, Anita
Grope, Ilze
Viksna, Ludmila
Dimina, Elina
Balasegaram, Sooria
author_facet Savrasova, Larisa
Krumina, Angelika
Cupeca, Hedija
Zeltina, Indra
Villerusha, Anita
Grope, Ilze
Viksna, Ludmila
Dimina, Elina
Balasegaram, Sooria
author_sort Savrasova, Larisa
collection PubMed
description In 2010 in Latvia, invasive pneumococcal disease (IPD) became a cause for concern and vaccination of infants with four doses of 7–valent pneumococcal conjugate vaccine (PCV7) commenced. In 2012, 10–valent pneumococcal conjugate vaccine (PCV10) (three doses at 2, 4, and 12–15 month of age) vaccination was introduced. We described incidence and serotype distribution of IPD in Latvia and investigated serotypes associated with death from IPD based on surveillance data. Adult vaccination against pneumococcal infection is not included in the national immunization program. Laboratory confirmed IPD cases are passively notified to the Center for Disease Prevention and Control of Latvia (CDPC) by laboratories and clinicians. We calculated incidence by age, sex, case fatality, and trend in serotypes by conducting a retrospective population-based cross-sectional study based on national IPD surveillance data. From 2012 to 2018 466 cases of IPD were reported. The highest notified incidence was in 2015 at 4.4/100,000, which fell to 3.9 in 2018. The highest mean annual IPD incidence was in infants (4.8) and in the elderly (6.0). PCV10 vaccine serotypes were the most prevalent in IPD cases up to 2015 with a decreasing trend from 50% (20/40) in 2012 to 19% (14/74) in 2018 (chi2 test for trend of odds = 0.000). PCV23nonPCV13 vaccine serotypes had an increasing trend and rose from 18% (7/40) to 34% (25/74) (chi2 test for trend of odds = 0.000). Non-Vaccine serotypes had an increasing trend and rose from 13% (5/40) to 27% (20/74) (chi2 test for trend of odds = 0.038). Reported total case fatality was 19% (87/466). The highest, at 36% (20/56), was reported in 2013. After adjusting for age, Streptococcus pneumoniae serotype 3 was associated with death from IPD (adjusted OR 2.3 95%CI 1.25–4.12 p 0.007). Surveillance data indicate evidence of serotype replacement with an increasing trend of serotype 19A and PPV23nonPCV13 and Non-Vaccine serotypes. Serotype 3 and age were associated with fatal IPD outcome. Further studies of S. pneumoniae carriage would be useful in providing more evidence to characterize serotypes' circulation.
format Online
Article
Text
id pubmed-8529945
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85299452021-10-22 Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018 Savrasova, Larisa Krumina, Angelika Cupeca, Hedija Zeltina, Indra Villerusha, Anita Grope, Ilze Viksna, Ludmila Dimina, Elina Balasegaram, Sooria Front Pediatr Pediatrics In 2010 in Latvia, invasive pneumococcal disease (IPD) became a cause for concern and vaccination of infants with four doses of 7–valent pneumococcal conjugate vaccine (PCV7) commenced. In 2012, 10–valent pneumococcal conjugate vaccine (PCV10) (three doses at 2, 4, and 12–15 month of age) vaccination was introduced. We described incidence and serotype distribution of IPD in Latvia and investigated serotypes associated with death from IPD based on surveillance data. Adult vaccination against pneumococcal infection is not included in the national immunization program. Laboratory confirmed IPD cases are passively notified to the Center for Disease Prevention and Control of Latvia (CDPC) by laboratories and clinicians. We calculated incidence by age, sex, case fatality, and trend in serotypes by conducting a retrospective population-based cross-sectional study based on national IPD surveillance data. From 2012 to 2018 466 cases of IPD were reported. The highest notified incidence was in 2015 at 4.4/100,000, which fell to 3.9 in 2018. The highest mean annual IPD incidence was in infants (4.8) and in the elderly (6.0). PCV10 vaccine serotypes were the most prevalent in IPD cases up to 2015 with a decreasing trend from 50% (20/40) in 2012 to 19% (14/74) in 2018 (chi2 test for trend of odds = 0.000). PCV23nonPCV13 vaccine serotypes had an increasing trend and rose from 18% (7/40) to 34% (25/74) (chi2 test for trend of odds = 0.000). Non-Vaccine serotypes had an increasing trend and rose from 13% (5/40) to 27% (20/74) (chi2 test for trend of odds = 0.038). Reported total case fatality was 19% (87/466). The highest, at 36% (20/56), was reported in 2013. After adjusting for age, Streptococcus pneumoniae serotype 3 was associated with death from IPD (adjusted OR 2.3 95%CI 1.25–4.12 p 0.007). Surveillance data indicate evidence of serotype replacement with an increasing trend of serotype 19A and PPV23nonPCV13 and Non-Vaccine serotypes. Serotype 3 and age were associated with fatal IPD outcome. Further studies of S. pneumoniae carriage would be useful in providing more evidence to characterize serotypes' circulation. Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529945/ /pubmed/34692599 http://dx.doi.org/10.3389/fped.2021.532489 Text en Copyright © 2021 Savrasova, Krumina, Cupeca, Zeltina, Villerusha, Grope, Viksna, Dimina and Balasegaram. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Savrasova, Larisa
Krumina, Angelika
Cupeca, Hedija
Zeltina, Indra
Villerusha, Anita
Grope, Ilze
Viksna, Ludmila
Dimina, Elina
Balasegaram, Sooria
Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018
title Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018
title_full Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018
title_fullStr Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018
title_full_unstemmed Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018
title_short Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018
title_sort invasive pneumococcal disease in latvia in pcv10 vaccination era, 2012–2018
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529945/
https://www.ncbi.nlm.nih.gov/pubmed/34692599
http://dx.doi.org/10.3389/fped.2021.532489
work_keys_str_mv AT savrasovalarisa invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018
AT kruminaangelika invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018
AT cupecahedija invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018
AT zeltinaindra invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018
AT villerushaanita invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018
AT gropeilze invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018
AT viksnaludmila invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018
AT diminaelina invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018
AT balasegaramsooria invasivepneumococcaldiseaseinlatviainpcv10vaccinationera20122018